Filing Analysis
Other SEC Filing
Filed Mar 30, 2026
LOW
Genasys Inc. has appointed Lawrence F. Hagenbuch to its Board of Directors and as Chairman of the Audit Committee, effective March 26, 2026. Mr. Hagenbuch brings extensive experience in financial oversight, turnaround management, and internal control enhancement from his roles at Crossplane Capital and Huron Consulting.
Key Facts
- Lawrence F. Hagenbuch (age 59) was elected as a director and appointed Chairman of the Audit Committee on March 26, 2026.
- Mr. Hagenbuch currently serves as an Operating Partner at Crossplane Capital and previously held a leadership role at Huron Consulting focused on turnarounds and interim management.
- He possesses significant public company board experience, currently serving as Audit Committee Chair for HireQuest, Inc. (NASDAQ: HQI).
- The appointment includes a grant of restricted stock units (RSUs) on the same terms as other non-employee directors.
- His professional background includes operational and financial leadership roles at GE Capital, J. Hilburn, and American National Can.
Other SEC Filing
Filed Mar 18, 2026
LOW
Genasys Inc. reported the results of its 2026 Annual Meeting of Stockholders held on March 17, 2026. Shareholders elected five directors, ratified the company's independent auditor, and approved executive compensation on an advisory basis.
Key Facts
- The meeting was held on March 17, 2026, with 25,083,917 shares represented out of 45,212,311 eligible shares.
- Five directors were elected for one-year terms: Richard S. Danforth, William H. Dodd, W. Craig Fugate, R. Rimmy Malhotra, and Susan Lee Schmeiser.
- Baker Tilly US, LLP was ratified as the independent registered public accounting firm for the fiscal year ending September 30, 2026, with 21,419,235 votes in favor.
- The advisory vote on executive compensation passed with 8,844,760 votes for and 5,107,733 votes against.
- Director Susan Lee Schmeiser received the highest 'Withheld' count among nominees with 4,044,163 withheld votes.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.